- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/08 - Bridged systems
Patent holdings for IPC class C07D 471/08
Total number of patents in this class: 2040
10-year publication summary
|
124
|
147
|
152
|
164
|
153
|
170
|
177
|
150
|
136
|
71
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4725 |
66 |
| Merck Sharp & Dohme LLC | 3734 |
57 |
| Wockhardt Limited | 194 |
48 |
| Boehringer Ingelheim International GmbH | 4502 |
41 |
| Purdue Pharma L.P. | 493 |
39 |
| Meiji Seika Pharma Co., Ltd. | 256 |
34 |
| Gilead Sciences, Inc. | 2219 |
31 |
| Skyhawk Therapeutics, Inc. | 147 |
27 |
| Novartis AG | 10279 |
23 |
| Vertex Pharmaceuticals Incorporated | 1586 |
23 |
| Nippon Chemiphar Co., Ltd. | 226 |
23 |
| Neurosearch A/S | 146 |
23 |
| Janssen Pharmaceutica N.V. | 3175 |
21 |
| Achillion Pharmaceuticals, Inc. | 158 |
21 |
| Hoffmann-La Roche Inc. | 3777 |
20 |
| Pfizer Inc. | 3380 |
19 |
| Amgen Inc. | 4418 |
19 |
| Takeda Pharmaceutical Company Limited | 2713 |
19 |
| Rigel Pharmaceuticals, Inc. | 507 |
18 |
| Centre National de La Recherche Scientifique | 11010 |
16 |
| Other owners | 1452 |